NCT03903029

Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline

AssessmeNt of Efficacy of Low-dose rosuvaStatin in KoRean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 242 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

This study aimed to evaluate the efficacy of low-dose rosuvastatin (10 mg) in the 4 statin benefit groups requiring high- or moderate-intensity statin therapy according to the 2013 American College of Cardiology/American Heart Association guideline in Korean population.

Detailed description

The primary endpoint was percentage reduction in low-density lipoprotein (LDL) cholesterol. Secondary endpoints were percentage reduction in other lipids and achievement of ≥50% reduction in LDL cholesterol. Intention-to-treat analyses were performed.

Conditions

• Dyslipidemias

Interventions

Type	Name	Description
DRUG	Low-dose (10mg) rosuvastatin	Low-dose (10mg) rosuvastatin in 4 statin benefit groups per 2013 ACC/AHA guideline

Timeline

• Start date: 2014-10-10
• Primary completion: 2015-07-05
• Completion: 2019-12-05
• First posted: 2019-04-04
• Last updated: 2019-04-04